Skip to content

Understanding How Different Therapies Help Reduce Pain and Improve Movement in People with Knee Arthritis.

Comparison of Immediate Effect of Interferential Current and Multimodal Therapy (Interferential Current plus Therapeutic Ultrasound) on Pain, Range of motion and Function in patients with Osteoarthritis of Knee. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/083664
Enrollment
60
Registered
2025-03-28
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M170- Bilateral primary osteoarthritis of knee Health Condition 2: M171- Unilateral primary osteoarthritisof knee

Interventions

Intervention1: Interferential Current: Participant Position: participant is in supine lying position. Technique 1 Four Interferential pad electrodes (4KHz, Square, 45 vector) will be placed around the

Sponsors

Sejal Chandrakant Suryawanshi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Primary OA knee patients Above 40 years age Both the gender Unilateral OA knee / bilateral Radiographic confirmation of knee OA by Radiologist.

Exclusion criteria

Exclusion criteria: Mimics arthritis Knee deformities Any neuromuscular conditions that affect participation in the study Secondary knee OA Past history of knee surgery.

Design outcomes

Primary

MeasureTime frame
For assessing Pain: Pressure pain Threshold (Algometer). Timepoint: 2 times pre and post intervention

Secondary

MeasureTime frame
For assessing Function: Time Up and Go (TUG), Five Time Sit to Stand Test (FTSTS).Timepoint: Post intervention

Countries

India

Contacts

Public ContactDr Niketa patel

College of physiotherapy Sumandeep Vidyapeeth Deemed to be University

niketa.cop@sumandeepvidyapeethdu.edu.in9099774190

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026